Prospects of MMX Mesalazine in Routine Outpatient Treatment of Ulcerative Colitis
Aim. A general review of treatment approaches to ulcerative colitis (UC) and the importance of oral 5-aminosalicylic acid (5-ASA) for its routine outpatient management.Key points. The choice of drug therapy for UC remission induction and maintenance is linked to the intestinal lesion extent and dise...
Saved in:
Main Authors: | Yu. P. Uspenskiy, S. V. Ivanov, Yu. A. Fominykh |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2022-03-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/606 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of mesalazine at ulcerative colitis with nutritional failure
by: A. V. Korolyov, et al.
Published: (2015-03-01) -
Mesalazine use tactics in the ulcerative colitis patients
by: A. V. Korolev, et al.
Published: (2013-03-01) -
Drug therapy: dose-response relationship of oral mesalazine in
inflammatory bowel disease
by: C. J. J. Mulder, et al.
Published: (1998-01-01) -
Influence of Mesalazine on Ferroptosis-Related Gene Expression in In Vitro Colorectal Cancer Culture
by: Joanna Słoka, et al.
Published: (2025-01-01) -
Mesalazine: a novel therapeutic agent for periodontitis via regulation of periodontal microbiota and inhibiting Porphyromonas gingivalis
by: Yuqi Wang, et al.
Published: (2025-01-01)